BST06
/ Biosyngen
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 16, 2024
Study on the Safety and Efficacy of BST06 Injection in the Treatment of Advanced Hepatocellular Carcinoma
(clinicaltrials.gov)
- P1 | N=16 | Not yet recruiting | Sponsor: BioSyngen Pte Ltd
New P1 trial • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1